My compounded semaglutide provider shut down. Where should I move my treatment?

Sorry that happened — that’s stressful. Don’t keep using an unverified compounded supply. The safest move is to transfer to an FDA‑approved product and a licensed prescriber/pharmacy. Brief plan and specific options:

1. Switch to an FDA‑approved semaglutide product (manufactured under FDA standards)

• Wegovy (Novo Nordisk) — approved specifically for chronic weight management; comes with a manufacturer titration schedule and patient support programs.
• Ozempic (Novo Nordisk) — approved for type 2 diabetes (commonly used off‑label for weight loss); often easier to get through insurance for diabetes.
• Rybelsus (Novo Nordisk) — oral semaglutide option if you prefer a pill and are being treated for type 2 diabetes.

1. Consider alternative GLP/GIP agents if appropriate

• Mounjaro (tirzepatide, Eli Lilly) or Zepbound (tirzepatide for weight loss) — different drug class profile that many clinicians are prescribing for weight loss or diabetes; discuss risks/benefits with your clinician.

1. Where to get a legitimate prescription and product

• See a local clinician: your primary care doctor, an endocrinologist, or an obesity medicine specialist. To find an obesity specialist, search the American Board of Obesity Medicine (abom.org) for certified physicians.
• Telehealth providers that commonly evaluate and, when appropriate, prescribe GLP‑1s: PlushCare, Carbon Health, One Medical, Ro (Roman), Hims & Hers. They can be useful if you need a quick evaluation, but you’ll still need an in‑person follow‑up if required.
• Fill prescriptions at major retail or mail‑order pharmacies (CVS, Walgreens, Walmart, Express Scripts, PillPack/Amazon Pharmacy) to ensure you’re getting genuine branded product.

1. Practical steps right now

• Stop using the compounded product until a licensed prescriber evaluates you.
• Bring notes of what dose you were taking, how long, and any side effects.
• Ask the new prescriber for a clear transition/titration plan — branded semaglutide dosing and pen strengths differ from compounded vials.
• Check insurance coverage ahead of time (Wegovy is often not covered for weight loss; Ozempic tends to be covered for diabetes). Ask about manufacturer savings/patient assistance (Novo Nordisk and Eli Lilly both have patient support programs).

1. Safety note

• The FDA has issued concerns about compounded semaglutide (sterility, dosing errors, contamination). Using FDA‑approved branded products significantly reduces those risks.

If you’d like, tell me (a) whether your prescribing reason was weight management or diabetes, and (b) your ZIP code or city — I can suggest nearby endocrinologists/obesity specialists or telehealth services that operate in your area.